Education Information
2021 - 2022
2021 - 2022Post Doctorate
University of Oxford, Neurology, England
2006 - 2007
2006 - 2007Post Doctorate
University of Pennsylvania, Neurology, United States Of America
2001 - 2006
2001 - 2006Post Doctorate
University of Texas at Austin, University Of Texas Medical Branch, Galveston, Tx, Abd, United States Of America
2000 - 2001
2000 - 2001Post Doctorate
University of Oxford, Neurology, United Kingdom
1995 - 2000
1995 - 2000Expertise In Medicine
Istanbul University, Istanbul Medical Faculty, Nöroloji, Turkey
1991 - 1995
1991 - 1995Masters (Non-Thesis)
Istanbul University, Istanbul Medical Faculty, Turkey
1989 - 1991
1989 - 1991Undergraduate
Istanbul University, Istanbul Medical Faculty, Turkey
Dissertations
2000
2000Expertise In Medicine
Diabetes mellitus olgularında subklinik polinöropati araştırmasında F takeodispersiyonun yeri 
Istanbul University, Istanbul Medical Faculty, Nöroloji
Foreign Languages
C1 Advanced
C1 AdvancedEnglish
Research Areas
Medicine
Health Sciences
Fundamental Medical Sciences
Internal Medicine Sciences
Neurology
Life Sciences
Neurobiology
Natural Sciences
Academic Titles / Tasks
2015 - Continues
2015 - ContinuesProfessor
Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience
2011 - 2015
2011 - 2015Associate Professor
Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience
Managerial Experience
2021 - Continues
2021 - ContinuesNeuro-oncology Board
EAN - European Academy of Neurology, Scientific Boards
2019 - 2022
2019 - 2022Uluslararası İşbirliği Projeleri Araştırma Destek Grubu (UPAG)
The Scientific and Technological Research Council of Turkey
2012 - 2022
2012 - 2022Head of Department
Istanbul University, Aziz Sancar Institute of Experimental Medicine, Department of Neuroscience
Non Academic Experience
2021 - 2022
2021 - 2022Sabbatical
Oxford Üniversitesi
2006 - 2007
2006 - 2007Doktora sonrası araştırmacı
UPenn, PA, ABD
2001 - 2006
2001 - 2006Doktora sonrası araştırmacı
UTMB, TX, ABD
2000 - 2001
2000 - 2001Doktora sonrası araştırmacı
Oxford Üniversitesi
Courses
Advising Theses
2024
2024Doctorate
Multipl sklerozda periferik regülatör hücre fonksiyonlarının hastalık patogenezi ile ilişkisinin değerlendirilmesi
Tüzün E. (Advisor)
E.AKBAYIR(Student)
2023
2023Doctorate
Multipl skleroz hastalığında miRNA'ların biyobelirteç olarak araştırılması
Tüzün E. (Advisor)
F.SAĞIR(Student)
2023
2023Doctorate
Dijital manipülasyonun yutmadaki etkinliği
Tüzün E. (Advisor)
G.KÖPRÜCÜ(Student)
2020
2020Doctorate
Nörodejeneratif hastalıklarda hücresel senesans mekanizmasının rolü
Tüzün E. (Advisor)
Y.MERİÇ(Student)
2020
2020Postgraduate
KİS'TEN RRMS'YE DÖNÜŞEN OLGULARDA B HÜCRE SPESİFİK GEN EKSPRESYON DÜZEYLERİNİN BELİRLENMESİ
Tüzün E. (Advisor)
İ.ERDEM(Student)
2019
2019Postgraduate
MS hastalarının bellek protein ekspresyon düzeylerinin kognitif rehabilitasyona bağlı değişimlerinin incelenmesi
Tüzün E. (Advisor)
E.AKBAYIR(Student)
2019
2019Doctorate
İdiyopatik intrakraniyal hipertansiyon (İİH) hastalığında antinöronal membran antikorlarının araştırılması
Tüzün E. (Advisor)
B.YETİMLER(Student)
2019
2019Doctorate
Multiple skleroz patofizyolojisinde perisitlerin rolü
Tüzün E. (Advisor)
C.AYSEL(Student)
2019
2019Doctorate
Genetik absans epilepsi modeli WAG/Rij sıçanlarda nanopartikül bağlı antiepileptik ilacın kan-beyin bariyeri dinamikleri ve antiepileptojenik etkileri
Tüzün E. (Advisor)
A.TEMİZYÜREK(Student)
2019
2019Postgraduate
Glisin reseptör antikoru pozitif kriptojenik fokal epilepside periferik kan hücrelerinin immünfenotiplendirilmesi ve antijenik yanıtlarının araştırılması
Tüzün E. (Advisor)
E.ŞANLI(Student)
2019
2019Postgraduate
Benign MS hastalarının B hücre immünfenotiplenmesi ve B hücresine özgü moleküllerin ekspresyon analizi
Tüzün E. (Advisor)
M.ŞEN(Student)
2019
2019Doctorate
Rolandik epilepsi olgularında dil bozuklukları ile anti nöronal antikor ilişkisinin incelenmesi
Tüzün E. (Advisor)
M.SAVAŞ(Student)
2018
2018Doctorate
Parkinson hastalığında görülen kognitif bozulmanın nörobiyolojik mekanizmalarının genetik ve nörogörüntüleme yaklaşımlarıyla incelenmesi
Tüzün E. (Advisor)
A.KIÇİK(Student)
2017
2017Doctorate
Nöro-Behçet Olgularının Serum İmmünoglobulin Örneklerinin Nöronal Sağkalım Üzerine Etkileri
TÜZÜN E.
E.Erdağ(Student)
2017
2017Postgraduate
Paraneoplastik nörolojik sendromlu kanser olgularında anti-nöronal antikorların prognostik değeri
Tüzün E. (Advisor)
Ç.AYDIN(Student)
2017
2017Doctorate
İyon kanalı antikorlarının nöronal membran protein ekspresyonu ve sağkalım üzerine etkileri
Tüzün E. (Advisor)
N.ALTUNCU(Student)
2016
2016Postgraduate
MUSK-REAKTİF LENFOSİTLERİN DENEYSEL OTOİMMÜN MİYASTENİA GRAVİS MODELİNDE KARAKTERİZASYONU VE BİYOBELİRTEÇ OLARAK DEĞERLERİNİN ARAŞTIRILMASI
TÜZÜN E.
M.Küçükerden(Student)
2016
2016Postgraduate
P2 pürinerjik reseptörlerinin nöronal sağkalım sürecindeki değişimleri
Tüzün E. (Advisor)
A.ÖRÇEN(Student)
2016
2016Postgraduate
Bipolar hastalarda nöroinflamasyon ve nöronal yıkım belirteçlerinin farklı hastalık alt gruplarında karşılaştırılmalı incelenmesi
Tüzün E. (Advisor)
U.AKCAN(Student)
2015
2015Postgraduate
Parkinson hastalığı ve akciğer kanserinde dj-1 ve αlfa-sinüklein'in ortak PI3K/AKT yolağı üzerindeki etkilerinin karşılaştırılması
Tüzün E. (Advisor)
N.YALÇINKAYA(Student)
2014
2014Postgraduate
Parkinson hastalığı'nın hayvan modelinde PI3K/Akt yolağı ile mitokondriyal, oksidatif ve apoptotik parametrelerin ilişkisi
Tüzün E. (Advisor)
H.HAYTURAL(Student)
2013
2013Postgraduate
Deneysel otoimmün MuSK miyastenia graviste sitokinlerin rolü
Tüzün E. (Advisor)
C.AYSEL(Student)
Published journal articles indexed by SCI, SSCI, and AHCI
2024
2024Gene Expression Levels Related to Histone Acetylation are Altered in Parkinson Disease Patients Parkinson Hastalarında Histon Asetilasyonu ile İlgili Gen İfade Düzeylerinin Değişimi
Tunoğlu S., Yalçin B., Yenilmez Tunoğlu E. N., KARAASLAN Z., BİLGİÇ B., Hanağasi H. A., et al.
Noropsikiyatri Arsivi
, vol.61, no.3, pp.271-274, 2024 (SCI-Expanded)
2024
2024Distinctive sleep complaints and polysomnographic findings in antibody subgroups of autoimmune limbic encephalitis
Küçükali C. İ., Yılmaz V., Karadeniz D., Akyıldız U. O., İlhan Algın D., Sarıtaş A. Ş., et al.
NEUROLOGICAL SCIENCES
, 2024 (SCI-Expanded)
2024
2024The Association Between Serum Levels of Glial Biomarkers, Clinical Severity and Electro-encephalography Features in Idiopathic West and Lennox-Gastaut Syndromes
Charkazzade M., Soylu S., Tüzün E., Yılmaz V., Sezgin M., Yapıcı Z., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.61, no.2, pp.128-134, 2024 (SCI-Expanded)
2024
2024Neuronal nicotinic acetylcholine receptor antibodies in autoimmune central nervous system disorders.
Pechlivanidou M., Vakrakou A. G., Karagiorgou K., Tüzün E., Karachaliou E., Chroni E., et al.
Frontiers in immunology
, vol.15, pp.1388998, 2024 (SCI-Expanded)
2024
2024Altered cerebrospinal fluid neurofilament light chain but not neurogranin levels are associated with response to ocrelizumab treatment in relapsing remitting multiple sclerosis: a preliminary study.
Kızılay T., Akbayir E., Erol R., Demir A. S., Özkan Yaşargün D., Yilmaz V., et al.
European neurology
, 2024 (SCI-Expanded)
2024
2024Patients with restless legs syndrome exhibit reduced serum colony-stimulating factor-1, humanin-like 3 and 10 levels
Gülçiçek A., Şanlı E., Şenel G. B., Karadeniz D., Timirci-Kahraman Ö., Küçükali C. İ., et al.
ACTA NEUROLOGICA BELGICA
, 2024 (SCI-Expanded)
2024
2024Glycine Receptor β-Targeting Autoantibodies Contribute to the Pathology of Autoimmune Diseases.
Wiessler A., Talucci I., Piro I., Seefried S., Hörlin V., Baykan B. B., et al.
Neurology(R) neuroimmunology & neuroinflammation
, vol.11, no.2, 2024 (SCI-Expanded)
2024
2024Autoimmune Encephalitis with Antibodies Against A-Amino-3hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor and γ-Aminobutyric Acid-Beta Receptor: Case Report
Doğan F. U., Samanci B., YILMAZ V., Hanağasi H. A., Gürvit İ. H., TÜZÜN E., et al.
Noropsikiyatri Arsivi
, vol.61, no.1, pp.94-96, 2024 (SCI-Expanded)
2024
2024Electrodiagnostic methods to verify Guillain-Barré syndrome subtypes in Istanbul: A prospective multicenter study
Tasdemir V., Sirin N. G., Cakar A., Culha A., Soysal A., Elmali A. D., et al.
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
, vol.29, no.1, pp.72-81, 2024 (SCI-Expanded)
2024
2024Peripheral blood regulatory B and T cells are decreased in patients with focal epilepsy
ŞANLI E., ŞİRİN İNAN N. G., KÜÇÜKALİ C. İ., Baykan B., ULUSOY C. A., BEBEK N., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.387, 2024 (SCI-Expanded)
2024
2024Seronegative NMOSD patients display distinctive peripheral blood T-cell subset frequencies
Sanli E., Karaaslan Z., Yilmaz V., Gunduz T., Kurtuncu M., Turkoglu R., et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
, 2024 (SCI-Expanded)
2024
2024Disease activity in chronic inflammatory demyelinating polyneuropathy: association between circulating B-cell subsets, cytokine levels, and clinical outcomes.
Ozdag Acarli A. N., Tuzun E., Sanli E., Koral G., Akbayir E., Cakar A., et al.
Clinical and experimental immunology
, vol.215, no.1, pp.65-78, 2024 (SCI-Expanded)
2024
2024Kelch-like Protein 11 (KLHL11) Antibodies in Children With Seizures of Undetermined Cause.
Tzartos J., Pechlivanidou M., Bosveli D., Ninou E., Yuceer H., Yalcin B., et al.
In vivo (Athens, Greece)
, vol.38, no.1, pp.351-357, 2024 (SCI-Expanded)
2023
2023Cerebellar antibodies in post-stroke sera of acute ischemic stroke patients
Atmaca M. M., Erdağ E., Demir S., Yüceer H., Çolak Atmaca M., Küçükali C. İ., et al.
IDEGGYOGYASZATI SZEMLE
, vol.76, no.11-12, pp.394-398, 2023 (SCI-Expanded)
2023
2023Silencing of FCRLB by shRNA ameliorates MuSK-induced EAMG in mice
Koral G., Ulusoy C., Cossins J., Lazaridis K., Türkoğlu R., Dong Y. Y., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.383, 2023 (SCI-Expanded)
2023
2023Chloride intracellular channel protein-1 (CLIC1) antibody in multiple sclerosis patients with predominant optic nerve and spinal cord involvement
KARAASLAN Z., Şengül-Yediel B., Yüceer-Korkmaz H., ŞANLI E., GEZEN AK D., DURSUN E., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.78, 2023 (SCI-Expanded)
2023
2023Distribution of peripheral blood mononuclear cell subtypes in patients with West syndrome: Impact of synacthen treatment
Soylu S., Cherkezzade M., Akbayır E., Korkmaz H., Koral G., Şanlı E., et al.
IMMUNOLOGY LETTERS
, vol.261, pp.17-24, 2023 (SCI-Expanded)
2023
2023Potential Role of Antibodies against Aquaporin-1 in Patients with Central Nervous System Demyelination
Pechlivanidou M., Xenou K., Tzanetakos D., Koutsos E., Stergiou C., Andreadou E., et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
, vol.24, no.16, 2023 (SCI-Expanded)
2023
2023Demyelinating Inflammatory Disorders of the Central Nervous System in the Era of COVID-19: Cases with Mild Infectious Symptoms
Özkan Yaşargün D., Türkoğlu R., Tüzün E.
NOROPSIKIYATRI ARSIVI
, vol.60, no.3, pp.191-193, 2023 (SCI-Expanded)
2023
2023Generalized Peripheric Nerve Hyperexcitability with Neuropathy: Case Series with Long-Term Outcome.
Akan O., Baysal L., Uzunhan T. A., Tüzün E.
Noro psikiyatri arsivi
, vol.61, no.2, pp.184-188, 2023 (SCI-Expanded)
2023
2023Autoimmune Mechanisms in Focal Epilepsy of Unknown Cause
ŞANLI E., YILMAZ V., TÜZÜN E.
NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY
, vol.40, no.3, pp.113-121, 2023 (SCI-Expanded)
2023
2023Serum IgG of patients with relapsing inflammatory optic neuropathy immunoreacts with Sox2-positive glial cells of the optic nerve
Erdağ E., Emekli A. S., Gündüz T., Küçükali C. İ., Kürtüncü M., Tüzün E.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.73, 2023 (SCI-Expanded)
2023
2023Perivascular PDGFRB+ cells accompany lesion formation and clinical evolution differentially in two different EAE models
Şekerdağ Kılıç E., Ulusoy C. A., Atak D., Özkan E., Gökyüzü A. B., Seyaj S., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.69, no.1, pp.104428, 2023 (SCI-Expanded)
2023
2023Ocrelizumab Treatment Modulates B-Cell Regulating Factors in Multiple Sclerosis
Ho S., Oswald E., Wong H. K., Vural A., Yilmaz V., Tüzün E., et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
, vol.10, no.2, 2023 (SCI-Expanded)
2023
2023The Effect of Lidocaine on the Experimental Model of Streptozotocin-Induced Alzheimer's Disease.
Tamam Y., Yokuş B., Tamam C., Yüceer H., Karahan S., Em B., et al.
Noro psikiyatri arsivi
, vol.60, no.1, pp.68-72, 2023 (SCI-Expanded)
2023
2023Glycine receptor autoantibody binding to the extracellular domain is independent from receptor glycosylation.
Rauschenberger V., Piro I., Kasaragod V. B., Hörlin V., Eckes A., Kluck C. J., et al.
Frontiers in molecular neuroscience
, vol.16, pp.1089101, 2023 (SCI-Expanded)
2023
2023Antibody induced seizure susceptibility and impaired cognitive performance in a passive transfer rat model of autoimmune encephalitis
Pişkin Ş. A., Korkmaz H., Ulusoy C. A., Şanlı E., Küçükali C. İ., Onat F., et al.
FRONTIERS IN IMMUNOLOGY
, vol.14, 2023 (SCI-Expanded)
2023
2023Increased neuropil antibody prevalence in COVID-19 patients with acute ischemic stroke
Baştan B., ERDAĞ TURGEON E., ŞANLI E., Bayar M. D., Şişman A. B., Atacan Yaşgüçlükal M., et al.
Neurological Research
, vol.45, no.11, pp.988-993, 2023 (SCI-Expanded)
2023
2023Elevated sTREM2 and NFL levels in patients with sepsis associated encephalopathy
ORHUN G., ESEN F., YILMAZ V., Ulusoy C., ŞANLI E., Yildirim E., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, vol.133, no.3, pp.327-333, 2023 (SCI-Expanded)
2022
2022Neuropsychiatry in the Century of Neuroscience
Marangozoğlu Samanci B., Yildizhan E., Tüzün E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.59, pp.1-2, 2022 (SCI-Expanded)
2022
2022Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios
Oezguen N., Yılmaz V., Horvath T. D., Akbayir E., Haidacher S. J., Hoch K. M., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.68, 2022 (SCI-Expanded)
2022
2022The modulatory action of C-Vx substance on the immune system in COVID-19
Tahrali I., Akdeniz N., Yilmaz V., Kucuksezer U. C., Oktelik F. B., Ozdemir O., et al.
EMERGING MICROBES & INFECTIONS
, vol.11, no.1, pp.2698-2710, 2022 (SCI-Expanded)
2022
2022Permanent Impairment of Language Functions in an Adolescent Case of Autoimmune Encephalitis Adölesan Bir Otoimmün Ensefalit Vakasında Kalıcı Dil Fonksiyon Bozukluğu
ŞANLI E., Savaş M., Öztürk G., Findik O. T. P., Başoğlu S., Akbeyaz H., et al.
Noropsikiyatri Arsivi
, vol.59, no.4, pp.338-341, 2022 (SCI-Expanded)
2022
2022Assessment of myelin oligodendrocyte glycoprotein antibodies and magnetic resonance spectroscopy in childhood-onset systemic lupus erythematosus
Kılıç H., Şahin S., Toprak M. F., Hatay G. H., Yilmaz K., Adrovic A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.1, no.1, pp.1-2, 2022 (SCI-Expanded)
2022
2022Reduced expression of inflammasome complex components in cluster headache.
Şahin E., Karaaslan Z., Şanlı E., Timirci Kahraman Ö., Ulusoy C., Kocasoy Orhan E., et al.
Headache
, vol.62, no.8, pp.967-976, 2022 (SCI-Expanded)
2022
2022Classical complement pathway factor alterations in narcolepsy.
Yüceer H., Gezen Ak D., Benbir Şenel G., Dursun E., Yilmaz V., Karadeniz D., et al.
Acta neuropsychiatrica
, vol.34, no.4, pp.212-219, 2022 (SCI-Expanded)
2022
2022Do the neurologists recognize autoimmune epilepsy well enough? What is the effect of the pandemic on this matter?
Yavuz E. N. V., Altindag E., Tuzun E., Baykan B.
NEUROLOGICAL SCIENCES
, vol.43, no.8, pp.5029-5037, 2022 (SCI-Expanded)
2022
2022Immune modulation as a consequence of SARS-CoV-2 infection
Gelmez M. Y., Öktelik F. B., Tahralı İ., Yılmaz V., Küçüksezer U. C., Akdeniz N., et al.
FRONTIERS IN IMMUNOLOGY
, vol.13, 2022 (SCI-Expanded)
2022
2022Cutaneous allodynia and thermal thresholds in chronic migraine: The effect of onabotulinumtoxinA
Ozarslan M., Matur Z., Tüzün E., Öge A. E.
CLINICAL NEUROLOGY AND NEUROSURGERY , vol.220, pp.107357, 2022 (SCI-Expanded)
2022
2022Blood-brain barrier targeted delivery of lacosamide-conjugated gold nanoparticles: Improving outcomes in absence seizures
Temizyürek A., Uğur Yılmaz C., Emik S., Akcan U., Atış M., Orhan N., et al.
EPILEPSY RESEARCH , vol.184, pp.106939, 2022 (SCI-Expanded)
2022
2022Kv5.1 antibody in epilepsy patients with unknown etiology
KÜÇÜKALİ C. İ., Sengul B., Gezen-Ak D., Dursun E., ERDAĞ E., AKPINAR G., et al.
EPILEPSY RESEARCH
, vol.182, 2022 (SCI-Expanded)
2022
2022Posterior Reversible Encephalopathy in Sepsis-Associated Encephalopathy: Experience from a Single Center.
Orhun G., Sencer S., Tüzün E., Bebek N., Ergin Özcan P., Barburoğlu M., et al.
Neurocritical care
, vol.36, pp.372-386, 2022 (SCI-Expanded)
2022
2022IgG4 Autoantibodies in Organ-Specific Autoimmunopathies: Reviewing Class Switching, Antibody-Producing Cells, and Specific Immunotherapies.
Koneczny I., Tzartos J., Mané-Damas M., Yilmaz V., Huijbers M. G., Lazaridis K., et al.
Frontiers in immunology
, vol.13, no.13, pp.834342, 2022 (SCI-Expanded)
2022
2022Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis.
Türkoğlu R., Baliç N., Kızılay T., Erol R., Akbayır E., Yılmaz V., et al.
Multiple sclerosis and related disorders
, vol.58, pp.103524, 2022 (SCI-Expanded)
2022
2022CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients
KARAASLAN Z., KÜRTÜNCÜ M., Akcay H. I., GÜNDÜZ T., Altunrende B., Turkoglu R., et al.
EUROPEAN NEUROLOGY
, vol.85, no.1, pp.69-71, 2022 (SCI-Expanded)
2022
2022Decline of humoral immune responses after natural SARS-CoV-2 infection can be efficiently reversed by vaccination
Oktelik F. B., Yilmaz V., Gelmez M. Y., Akdeniz N., Pamukcu C., Sutlu T., et al.
CANADIAN JOURNAL OF MICROBIOLOGY
, vol.68, pp.543-550, 2022 (SCI-Expanded)
2022
2022Biomarker Value of Neurofilaments and Glial Fibrillary Acidic Protein in Central Nervous System Lymphoma and Tumors Merkezi Sinir Sistemi Lenfoma ve Tümörlerinde Nörofilamentlerin ve Glial Fibriler Asidik Proteinin Biyobelirteç Değeri
YÜCEER H., TÜZÜN E.
Noropsikiyatri Arsivi
, vol.59, no.4, pp.253-254, 2022 (SCI-Expanded)
2022
2022Cerebrospinal fluid level of neurofilament light chain is associated with increased disease activity in neuro-Behcet's disease
Karaaslan Z., Şanlı E., Timirci-Kahraman Ö., Yılmaz V., Akbayır E., Koral G., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.52, no.4, pp.1266-1273, 2022 (SCI-Expanded)
2022
2022INCREASED SERUM CITRULLINATED HISTONE H3 LEVELS IN COVID-19 PATIENTS WITH ACUTE ISCHEMIC STROKE AKUT ISCHAEMIÁS STROKE-BAN SZENVEDÔ COVID-19-BETEGEK KÖRÉBEN MEGNÔ A SZÉRUM CITRULLINÁLT HISZTON H3-SZINTJE
Bayar M. D., Şişman A. B., Koral G., Çirak S., TÜZÜN E., Günaydin S., et al.
Ideggyogyaszati Szemle
, vol.75, no.5-6, pp.191-198, 2022 (SCI-Expanded)
2021
2021Expression of Akt1 and p-Akt1 in peripheral T cell subsets of multiple sclerosis patients.
Oktelik F. B., Yilmaz V., Turkoglu R., Akbayir E., Tuzun E., Deniz G., et al.
Acta neurologica Belgica
, vol.121, no.6, pp.1777-1782, 2021 (SCI-Expanded)
2021
2021Phosphorylated Neurofilament Heavy Chain (pNFH) in Clinically Isolated Syndrome and Multiple Sclerosis
TÜZÜN E., ŞANLI E., Akbayir E., Turkoglu R.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.58, no.4, pp.255-256, 2021 (SCI-Expanded)
2021
2021miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study
SAĞIR F., Tunali N. E., TOMBUL T., Koral G., Cirak S., YILMAZ V., et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS
, no.11, pp.720-726, 2021 (SCI-Expanded)
2021
2021Cerebrospinal fluid level of phosphorylated neurofilament heavy chain is higher in converting clinically isolated syndrome and correlates with CAMP response element-binding protein concentration
Gencer M., Koral G., ŞANLI E., Cirak S., Akbayir E., YÜCEER H., et al.
Neurological Sciences and Neurophysiology
, vol.38, no.4, pp.256-261, 2021 (SCI-Expanded)
2021
2021Glial fibrillary acidic protein (GFAP)-antibody in children with focal seizures of undetermined cause.
Savaş M., Tzartos J., Küçükali C., Dursun E., Karagiorgou K., Gezen-Ak D., et al.
Acta neurologica Belgica
, vol.121, no.5, pp.1275-1280, 2021 (SCI-Expanded)
2021
2021Serum glial fibrillary acidic protein (GFAP)-antibody in idiopathic intracranial hypertension.
Yetimler B., Tzartos J., Şengül B., Dursun E., Ulukan Ç., Karagiorgou K., et al.
The International journal of neuroscience
, vol.131, no.8, pp.775-779, 2021 (SCI-Expanded)
2021
2021Effects of Teriflunomide on B Cell Subsets in MuSK-Induced Experimental Autoimmune Myasthenia Gravis and Multiple Sclerosis
YILMAZ V., Ulusoy C., Hajtovic S., Turkoglu R., Kurtuncu M., Tzartos J., et al.
Immunological Investigations
, vol.50, pp.671-684, 2021 (SCI-Expanded)
2021
2021Paraneoplastic cerebellar degeneration in a patient with multiple myeloma
KÜRTÜNCÜ M., TÜZÜN E.
LEUKEMIA & LYMPHOMA
, vol.62, no.10, pp.2556-2557, 2021 (SCI-Expanded)
2021
2021Peripheral blood B cell subset ratios and expression levels of B cell-associated genes are altered in benign multiple sclerosis
Turkoglu R., YILMAZ V., ÖZDEMİR Ö., Akbayir E., Benbir G., Arsoy E., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.52, 2021 (SCI-Expanded)
2021
2021Impact of Autoimmune Demyelinating Brain Disease Sera on Pericyte Survival
Ulusoy C., Şekerdağ E., YILMAZ V., Yilmaz A. B., Atak D., Vural A., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, no.2, pp.83-86, 2021 (SCI-Expanded)
2021
2021Aquaporin-4 Gene Polymorphisms in Relapsing Inflammatory Optic Neuropathy and RANKL in Glioblastoma: Research and Progress on Biomarkers.
Şanli E., Tüzün E.
Noro psikiyatri arsivi
, vol.58, no.2, pp.81-82, 2021 (SCI-Expanded)
2021
2021Association of the kynurenine pathway metabolites with clinical, cognitive features and IL-1β levels in patients with schizophrenia spectrum disorder and their siblings
Noyan H., ERDAĞ E., TÜZÜN E., YAYLIM İ., KÜÇÜKHÜSEYİN Ö., HAKAN M. T., et al.
Schizophrenia Research
, vol.229, pp.27-37, 2021 (SCI-Expanded)
2021
2021Adaptive immunity cells are differentially distributed in the peripheral blood of glycine receptor antibody-positive patients with focal epilepsy of unknown cause.
Sanli E., Akbayir E., Kuçukali C. İ., Baykan B., Sirin N. G., Bebek N., et al.
Epilepsy research
, vol.170, pp.106542, 2021 (SCI-Expanded)
2021
2021CSF levels of HoxB3 and YKL-40 may predict conversion from clinically isolated syndrome to relapsing remitting multiple sclerosis.
Tamam Y., Gunes B., Akbayir E., Kizilay T., Karaaslan Z., Koral G., et al.
Multiple sclerosis and related disorders
, vol.48, no.1, pp.102697, 2021 (SCI-Expanded)
2021
2021The search for an autoimmune origin of psychotic disorders: Prevalence of autoantibodies against hippocampus antigens, glutamic acid decarboxylase and nuclear antigens.
Hoffmann C., Zong S., Mané-Damas M., Stevens J., Malyavantham K., Küçükali C. İ., et al.
Schizophrenia research
, vol.228, pp.462-471, 2021 (SCI-Expanded)
2021
2021Inflammation and regulatory T cell genes are differentially expressed in peripheral blood mononuclear cells of Parkinson's disease patients.
Karaaslan Z., Kahraman Ö. T., Şanlı E., Ergen H. A., Ulusoy C., Bilgiç B., et al.
Scientific reports
, vol.11, no.1, pp.2316, 2021 (SCI-Expanded)
2021
2021Central Role of T Follicular Helper Cells in Myasthenia Gravis.
Wu N., Tüzün E., Cheng Y., Yan L., Wu Y., Rao J., et al.
Noro psikiyatri arsivi
, vol.58, no.1, pp.68-72, 2021 (SCI-Expanded)
2021
2021Impact of calcitriol and an AKT inhibitor, AT7867, on survival of rat C6 glioma cells
KÜÇÜKHÜSEYİN Ö., ÇAKİRİS A., HAKAN M. T., Horozoglu C., TÜZÜN E., YAYLIM İ.
BIOTECHNOLOGY & BIOTECHNOLOGICAL EQUIPMENT
, vol.35, no.1, pp.730-738, 2021 (SCI-Expanded)
2021
2021Common Denominators in the Immunobiology of IgG4 Autoimmune Diseases: What Do Glomerulonephritis, Pemphigus Vulgaris, Myasthenia Gravis, Thrombotic Thrombocytopenic Purpura and Autoimmune Encephalitis Have in Common?
Koneczny I., YILMAZ V., Lazaridis K., Tzartos J., Lenz T. L., Tzartos S., et al.
FRONTIERS IN IMMUNOLOGY
, vol.11, 2021 (SCI-Expanded)
2021
2021Serum antiganglioside antibodies in patients with autoimmune limbic encephalitis
Culha Oktar A., Selcuk O., Elmas Tunc C., IŞILDAK Ş., ŞANLI E., YILMAZ V., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.51, no.5, pp.2570-2574, 2021 (SCI-Expanded)
2020
2020The treatment effect on peripheral B cell markers in antibody positive myasthenia gravis patients
YILMAZ V., TÜZÜN E., DURMUŞ TEKÇE H., Oflazer P., Aysal F., Parman Y., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.349, 2020 (SCI-Expanded)
2020
2020Peripheral blood expression levels of inflammasome complex components in two different focal epilepsy syndromes
Ulusoy C., Vanlı-Yavuz E., Şanlı E., Timirci-Kahraman Ö., Yılmaz V., Bebek N., et al.
Journal of Neuroimmunology
, vol.347, 2020 (SCI-Expanded)
2020
2020Serum Immunoglobulin G of Neuro-Behçet’s Disease Patients Reduce Cerebral Expression Levels of Survival Pathway Factors
Erdağ E., Şahin-Özkartal C., Küçükali C. İ., Arıcıoğlu F., Tüzün E.
NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY
, vol.37, no.3, pp.118-123, 2020 (SCI-Expanded)
2020
2020The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.
Arslan D. B., Gurvit H., Genc O., Kicik A., Eryurek K., Cengiz S., et al.
Journal of neural transmission (Vienna, Austria : 1996)
, vol.127, pp.1285-1294, 2020 (SCI-Expanded)
2020
2020Laboratory and clinical correlates of brain atrophy in Neuro-Behçet's disease
Gündüz T., Kürtüncü M., Matur Z., Tüzün E., Limon U., Tanyildiz B., et al.
Journal of the Neurological Sciences
, vol.414, 2020 (SCI-Expanded)
2020
2020Co-existence of multiple sclerosis and anti-NMDA receptor encephalitis: A case report and review of literature.
Gulec B., Kurucu H., Bozbay S., Dikmen Y., Sayman H., Tuzun E., et al.
Multiple sclerosis and related disorders
, vol.42, pp.102075, 2020 (SCI-Expanded)
2020
2020Nivolumab-induced autoantibody negative limbic encephalitis in a patient with Hodgkin lymphoma
Erol-Yıldız R., Kızılay T., TÜZÜN E., Mısırlı H., Türkoğlu R.
Leukemia and Lymphoma
, vol.61, no.6, pp.1519-1521, 2020 (SCI-Expanded)
2020
2020Small ubiquitin-related modifier (SUMO) 3 and SUMO4 gene polymorphisms in Parkinson's disease
Küçükali C. İ., Salman B., Yüceer H., Ulusoy C. A., Abacı N., Ekmekci S., et al.
NEUROLOGICAL RESEARCH
, vol.42, no.6, pp.451-457, 2020 (SCI-Expanded)
2020
2020NLRP1-Mediated Antidepressant Effect of Ketamine in Chronic Unpredictable Mild Stress Model in Rats.
Aricioğlu F., Yalcinkaya C., Ozkartal C., Tuzun E., Sirvanci S., Kucukali C. İ., et al.
Psychiatry investigation
, vol.17, pp.283-291, 2020 (SCI-Expanded)
2020
2020Plasma levels of inflammatory mediators in vestibular migraine.
Karaaslan Z., Ozcelik P., Ulukan Ç., Ulusoy C. A., Orhan K. S., Orhan E., et al.
The International journal of neuroscience
, vol.130, no.4, pp.330-335, 2020 (SCI-Expanded)
2020
2020Serum glial fibrillary acidic protein (GFAP)-antibody in idiopathic intracranial hypertension
Yetimler B., Tzartos J., Şengül B., Dursun E., Ulukan Ç., Karagiorgou K., et al.
International Journal Of Neuroscience , vol.131, no.8, pp.775-779, 2020 (SCI-Expanded)
2020
2020Sleep disturbance and cognitive decline in multiple sclerosis patients with isolated optic neuritis as the first demyelinating event
Türkoğlu R., Benbir G., Özyurt S., Arsoy E., Akbayır E., Turan S., et al.
International Ophthalmology
, vol.40, no.1, pp.151-158, 2020 (SCI-Expanded)
2020
2020Serum levels of inflammasome pathway factors in clinically isolated syndrome and multiple sclerosis patients: a pilot study
Tamam Y., Yuceer H., Duzel B., Sen M., Ulusoy C., Tuzun E.
CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY
, vol.45, no.2, pp.237-240, 2020 (SCI-Expanded)
2020
2020Impact of epilepsy on language and discourse: Two self-limited focal epileptic syndromes of childhood
Savas M., TUNÇER A. M., Cokar A. O., Demirbilek A. V., Tuzun E.
EPILEPSY & BEHAVIOR
, vol.102, 2020 (SCI-Expanded)
2020
2020Diagnosing acute brain dysfunction due to sepsis
Esen F., Orhun G., Özcan P. E., Brenes Bastos A. R., TÜZÜN E.
Neurological Sciences
, vol.41, no.1, pp.25-33, 2020 (SCI-Expanded)
2019
2019Antidepressant-like effects of agmatine and NOS inhibitors in chronic unpredictable mild stress model of depression in rats: The involvement of NLRP inflammasomes
Ozkartal C. S., Tuzun E., Kucukali C. I., Ulusoy C. A., Giris M., ARICIOĞLU F.
BRAIN RESEARCH
, vol.1725, 2019 (SCI-Expanded)
2019
2019Impact of fingolimod on CD4+T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients
Kurtuncu M., Yilmaz V., Akcay H. I., Turkoglu R., Altunrende B., Cinar S., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.337, 2019 (SCI-Expanded)
2019
2019Absence of autoantibodies against neuronal surface antigens in sera of patients with psychotic disorders
Mané-Damas M., Hoffmann C., Molenaar P., Losen M., Zong S., Titulaer M., et al.
JAMA Psychiatry , vol.77, no.3, pp.322-325, 2019 (SCI-Expanded)
2019
2019Cytokine-chemokine and cognitive profile of multiple sclerosis patients with predominant optic nerve and spinal cord involvement
Sen M., Akbayir E., Mercan O., Arsoy E., Gencer M., Yilmaz V., et al.
JOURNAL OF SPINAL CORD MEDICINE
, 2019 (SCI-Expanded)
2019
2019Enhanced NLRP3 and DEFA1B Expression During the Active Stage of Parenchymal Neuro-Behcet's Disease
UGUREL E., ERDAG E., KUCUKALI C. İ., OLCAY A., Sanli E., AKBAYIR E., et al.
IN VIVO
, vol.33, no.5, pp.1493-1497, 2019 (SCI-Expanded)
2019
2019Inflammatory biomarkers in epilepsy
Karaaslan Z., Tuzun E.
NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY
, vol.36, no.3, pp.129-135, 2019 (SCI-Expanded)
2019
2019Neuroinflammation Mediators are Reduced in Sera of Parkinson's Disease Patients with Mild Cognitive Impairment.
Kıçık A., Tüzün E., Erdoğdu E., Bılgıç B., Tüfekçıoğlu Z., Öztürk-Işik E., et al.
Noro psikiyatri arsivi
, vol.57, pp.15-17, 2019 (SCI-Expanded)
2019
2019Inflammation and Neurodegeneration in Patients with Early-Stage and Chronic Bipolar Disorder
Karabulut S., Tasdemir I., Akcan U., Kucukali C. I., Tuzun E., Cakir S.
TURK PSIKIYATRI DERGISI
, vol.30, no.2, pp.75-81, 2019 (SSCI)
2019
2019Antidepressant-like Effects Induced by Chronic Blockade of the Purinergic 2X7 Receptor through Inhibition of Non-like Receptor Protein 1 Inflammasome in Chronic Unpredictable Mild Stress Model of Depression in Rats
ARICIOĞLU F., Ozkartal C. S., Bastaskin T., Tuzun E., Kandemir C., ŞİRVANCI S., et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE
, vol.17, no.2, pp.261-272, 2019 (SCI-Expanded)
2019
2019Serum orexin-A levels are associated with disease progression and motor impairment in multiple sclerosis
Gencer M., Akbayir E., Sen M., Arsoy E., Yilmaz V., Bulut N., et al.
NEUROLOGICAL SCIENCES
, vol.40, no.5, pp.1067-1070, 2019 (SCI-Expanded)
2019
2019Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid
Timirci-Kahraman O., Karaaslan Z., Tuzun E., Kurtuncu M., Baykal A. T., Gunduz T., et al.
ACTA NEUROLOGICA BELGICA
, no.1, pp.101-111, 2019 (SCI-Expanded)
2019
2019Association Between Inflammatory Markers and Cognitive Outcome in Patients with Acute Brain Dysfunction Due to Sepsis
Orhun G., Tuzun E., Ergin Ozcan P., Ulusoy C., Yildirim E., Kucukerden M., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.56, pp.63-70, 2019 (SCI-Expanded)
2019
2019Follow-up of patients with epilepsy harboring antiglycine receptor antibodies
EKIZOĞLU E., Baykan B., SEZGIN M., ERDAG E., GUNDOGDU-UNVERENGIL G., VANLı-YAVUZ E., et al.
EPILEPSY & BEHAVIOR
, pp.103-107, 2019 (SCI-Expanded)
2019
2019Adipokines in Multiple Sclerosis Patients with and without Optic Neuritis as the First Clinical Presentation
Duzel B., Tamam Y., Coban A., Tuzun E.
IMMUNOLOGICAL INVESTIGATIONS
, vol.48, no.2, pp.190-197, 2019 (SCI-Expanded)
2019
2019Neuroimaging Findings in Sepsis-Induced Brain Dysfunction: Association with Clinical and Laboratory Findings
Orhun G., Esen F., Ozcan P. E., Sencer S., Bilgic B., Ulusoy C., et al.
NEUROCRITICAL CARE
, vol.30, pp.106-117, 2019 (SCI-Expanded)
2019
2019Microbiota stratification identifies disease-specific alterations in neuro-Behcet's disease and multiple sclerosis
Oezguen N., Yalcinkaya N., Kucukali C. I., Dahdouli M., Hollister E. B., Luna R. A., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, vol.37, no.6, pp.58-66, 2019 (SCI-Expanded)
2019
2019Brain Volume Changes in Patients with Acute Brain Dysfunction Due to Sepsis
Orhun G., TÜZÜN E., Bilgiç B., Ergin Özcan P., Sencer S., Barburoğlu M., et al.
Neurocritical Care
, 2019 (SCI-Expanded)
2018
2018Alpha7 acetylcholine receptor autoantibodies are rare in sera of patients diagnosed with schizophrenia or bipolar disorder
Hoffmann C., Stevens J., Zong S., van Kruining D., Saxena A., Kucukali C. I., et al.
PLOS ONE
, vol.13, no.12, 2018 (SCI-Expanded)
2018
2018Intracranial hypertension related to cerebral venous thrombosis; and acute ischemic stroke with micro-infarcts associated with IgG4-related disease
Ekizoglu E., Coban O., Ulukan C., Ak D. G., Dursun E., Tuzun E., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, vol.128, no.11, pp.1097-1099, 2018 (SCI-Expanded)
2018
2018Investigation of neuronal auto-antibodies in children diagnosed with epileptic encephalopathy of unknown cause
Tekturk P., Baykan B., Erdag E., Peach S., Sezgin M., Yapici Z., et al.
BRAIN & DEVELOPMENT
, vol.40, no.10, pp.909-917, 2018 (SCI-Expanded)
2018
2018LRP4 antibody positive amyotrophic lateral sclerosis patients display neuropil-reactive IgG and enhanced serum complement levels
Tuzun E., Gezen-Ak D., Tzartos J., Dursun E., Giris M., Zisimopoulou P., et al.
IMMUNOLOGY LETTERS
, vol.203, pp.54-56, 2018 (SCI-Expanded)
2018
2018Immunopathological Factors Associated with Disability in Multiple Sclerosis
TÜZÜN E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.55, pp.26-30, 2018 (SCI-Expanded)
2018
2018A SOD2 Polymorphism is Associated with Abnormal Quantitative Sensory Testing in Type 2 Diabetic Patients
Isikli A., Kubat-Uzum A., Satman I., Matur Z., Oge A. E., Kucukali M. I., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.55, no.3, pp.276-279, 2018 (SCI-Expanded)
2018
2018Evidence of linkage to chromosome 5p13.2-q11.1 in a large inbred family with genetic generalized epilepsy
Kinay D., Oliver K. L., Tuzun E., Damiano J. A., Ulusoy C., Andermann E., et al.
EPILEPSIA
, vol.59, no.8, 2018 (SCI-Expanded)
2018
2018Effect of LGI1 antibody-positive IgG on hippocampal neuron survival: a preliminary study
Aysit-Altuncu N., Ulusoy C., ÖZTÜRK G., Tuzun E.
NEUROREPORT
, vol.29, no.11, pp.932-938, 2018 (SCI-Expanded)
2018
2018Peripheral blood memory B cell frequency predicts conversion from clinically isolated syndrome to multiple sclerosis
Aktura S. D., Yilmaz V., Ozkan-Yasargun D., Ulusoy C., Tuzun E., Turkoglu R.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.23, pp.9-14, 2018 (SCI-Expanded)
2018
2018Delta Brush Pattern Is Not Unique to NMDAR Encephalitis: Evaluation of Two Independent Long-Term EEG Cohorts
Baykan B., Tuncer O. G., Vanli-Yavuz E. N., Kirac L. B., Gundogdu G., Bebek N., et al.
CLINICAL EEG AND NEUROSCIENCE
, vol.49, no.4, pp.278-284, 2018 (SCI-Expanded)
2018
2018Prognostic Factors in Anti-Neurona Antibody Positive Patients
Aydin C., Celik S. Y., Icoz S., Ulusoy C. A., Gunduz T., Akman Demir G., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.55, no.2, pp.189-194, 2018 (SCI-Expanded)
2018
2018Mechanisms of action of intravenous immunoglobulin in septic encephalopathy
Esen F., Ozcan P. E., Tuzun E., Boone M. D.
REVIEWS IN THE NEUROSCIENCES
, vol.29, no.4, pp.417-423, 2018 (SCI-Expanded)
2018
2018The psychiatric profiles of patients with temporal lobe epilepsy associated with neuronal auto-antibodies
Sezgin M., Cikrikcili U., Kulaksizoglu I. B., Vanli-Yavuz E. N., Bebek N., Tuzun E., et al.
NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY
, vol.35, no.2, pp.84-90, 2018 (SCI-Expanded)
2018
2018Bipolar disorder patients display reduced serum complement levels and elevated peripheral blood complement expression levels
Akcan U., Karabulut S., Kucukali C. I., Cakir S., Tuzun E.
ACTA NEUROPSYCHIATRICA
, vol.30, no.2, pp.70-78, 2018 (SCI-Expanded)
2018
2018Reduced Peripheral Blood Mononuclear Cell ROCK1 and ROCK2 Levels in Obstructive Sleep Apnea Syndrome
Aydin S., Ozdemir C., Kucukali C. I., Sokucu S. N., Giris M., Akcan U., et al.
IN VIVO
, vol.32, no.2, pp.319-325, 2018 (SCI-Expanded)
2018
2018Effects of computer-assisted cognitive rehabilitation in benign multiple sclerosis
Arsoy E., Tuzun E., Turkoglu R.
TURKISH JOURNAL OF MEDICAL SCIENCES
, vol.48, no.5, pp.999-1005, 2018 (SCI-Expanded)
2018
2018Chronic mild stress-induced anhedonia in rats is coupled with the upregulation of inflammasome sensors: a possible involvement of NLRP1
Ozkartal C. S., ARICIOĞLU F., Tuzun E., Kucukali C. I.
PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY
, vol.28, no.3, pp.236-244, 2018 (SCI-Expanded)
2018
2018Immunopathology in drug resistant mesial temporal lobe epilepsy with different types of hippocampal sclerosis
TEZER FİLİK F. İ., FIRAT A., Tuzun E., Unal I., Soylemezoglu F., BİLGİNER B., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, vol.128, no.5, pp.421-428, 2018 (SCI-Expanded)
2018
2018Transcriptional repressor Blimp1 regulates follicular regulatory T-cell homeostasis and function
Yang G., Yang X., Zhang J., Li G., Zheng D., Peng A., et al.
IMMUNOLOGY
, vol.153, no.1, pp.105-117, 2018 (SCI-Expanded)
2017
2017Investigation of anti-neuronal antibodies in status epilepticus of unknown etiology: a prospective study
Atmaca M. M., Tuzun E., Erdag E., Bebek N., Baykan B., Gurses C.
ACTA NEUROLOGICA BELGICA
, vol.117, no.4, pp.841-848, 2017 (SCI-Expanded)
2017
2017Investigation of DNA repair genes in patients with obsessive-compulsive disorder
Celik R., Iplik E. S., Kucukali C. İ., Tuzun E., Cakmakoglu B.
ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
, vol.26, no.8, pp.1269-1273, 2017 (SCI-Expanded)
2017
2017A NMOSD case with multifocal nervous system involvement in a single attack
Tanyel T., Karaaslan Z., Misirli H., Gencer M., Tuzun E., Turkoglu R.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.18, pp.82-84, 2017 (SCI-Expanded)
2017
2017Glial and neuronal antibodies in patients with idiopathic intracranial hypertension
Altiokka-Uzun G., Erdag E., Baykan B., TZARTOS J., Gezen-Ak D., Samanci B., et al.
NEUROLOGICAL SCIENCES
, no.10, pp.1817-1822, 2017 (SCI-Expanded)
2017
2017Impact of Topiramate on Rat Phrenic Nerve-Hemidiaphragm Preparations
Kucukali C. I., Tuzun E., NURTEN A.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.54, no.3, pp.202-204, 2017 (SCI-Expanded)
2017
2017Anti-Neuronal Autoantibodies in Both Drug Responsive and Resistant Focal Seizures with Unknown Cause
Gozubatik-Celik G., Ozkara C., Ulusoy C. A., Gunduz A., Delil S., Yeni N., et al.
EPILEPSY RESEARCH
, vol.135, pp.131-136, 2017 (SCI-Expanded)
2017
2017Neuron-specific enolase levels as a marker for possible neuronal damage in idiopathic intracranial hypertension
Samanci Y., Samanci B., Sahin E., Altiokka-Uzun G., Kucukali C. I., Tuzun E., et al.
ACTA NEUROLOGICA BELGICA
, vol.117, no.3, pp.707-711, 2017 (SCI-Expanded)
2017
2017Recurrent tumefactive demyelinating lesions: a pathological study
Turkoglu R., Lassmann H., Aker F. V., Tzartos J., Tzartos S., Tuzun E.
CLINICAL NEUROPATHOLOGY
, vol.36, no.4, pp.195-198, 2017 (SCI-Expanded)
2017
2017Elevated IL-4 and IFN-γ Levels in Muscle Tissue of Patients with Dermatomyositis
Giris M., Durmus H., Yetimler B., Tasli H., Parman Y., Tuzun E.
IN VIVO
, no.4, pp.657-660, 2017 (SCI-Expanded)
2017
2017Investigation of the prognostic value of adipokines in multiple sclerosis
Coban A., Duzel B., Tuzun E., Tamam Y.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, vol.15, pp.11-14, 2017 (SCI-Expanded)
2017
2017Clinical, Electrophysiological, and Serological Evaluation of Patients with Cramp-Fasciculation Syndrome
Poyraz M., Matur Z., Aysal F., Tuzun E., Hanoglu L., Oge A. E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.54, no.2, pp.183-186, 2017 (SCI-Expanded)
2017
2017Evidence for potential involvement of pro-inflammatory adipokines in the pathogenesis of idiopathic intracranial hypertension
Samanci B., Samancı Y., Tuzun E., Altiokka-Uzun G., Ekizoglu E., Icoz S., et al.
CEPHALALGIA
, vol.37, no.6, pp.525-531, 2017 (SCI-Expanded)
2017
2017Effects of in vivo and in vitro administration of neuro-Behcet's disease IgG
Erdag E., Sahin C., Kucukali C. İ., Bireller S., Kucukerden M., Kurtuncu M., et al.
NEUROLOGICAL SCIENCES
, no.5, pp.833-843, 2017 (SCI-Expanded)
2017
2017Agmatine produces antidepressant effect via modulation of neuroinflammation in chronic unpredictable mild stress model of rats: Implication in inflammatory perspective of depression
Şahin-Özkartal C., Arıcıoğlu F., TÜZÜN E., Keleş R., Kandemir C., Şirvancı S., et al.
KLİNİK PSİKOFARMAKOLOJİ BULTENİ-BULLETİN OF CLİNİCAL PSYCHOPHARMACOLOGY , vol.27, no.1, pp.184-188, 2017 (SCI-Expanded)
2017
2017Impact of Neuro-Behcet Disease Immunoglobulin G on Neuronal Apoptosis
Giris M., Bireller S., Kucukali C. I., Hanagasi H. A., Degirmencioglu S., Tuzun E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.54, no.1, pp.67-71, 2017 (SCI-Expanded)
2017
2017VIABILITY OF SH-SY5Y CELLS IS ASSOCIATED WITH PURINERGIC P2 RECEPTOR EXPRESSION ALTERATIONS
Orcen A., Yilmaz V., Giris M., Akcan U., Tuzun E., Erten G.
ACTA BIOLOGICA HUNGARICA
, vol.68, no.1, pp.22-34, 2017 (SCI-Expanded)
2017
2017Neuronal nitric oxide synthase polymorphisms in obsessive-compulsive disorder
TOPALOGLU M., Tuzun E., GULEC H., Bireller E. S., Cakmakoglu B., Kucukali C. İ.
NORDIC JOURNAL OF PSYCHIATRY
, vol.71, no.2, pp.115-119, 2017 (SCI-Expanded)
2017
2017Are linear AChR epitopes the real culprit in ocular myasthenia gravis?
Wu X., Tuzun E.
MEDICAL HYPOTHESES
, vol.99, pp.26-28, 2017 (SCI-Expanded)
2017
2017Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice
Ulusoy C. A., Cavus F., Yilmaz V., Tuzun E.
IMMUNOLOGICAL INVESTIGATIONS
, vol.46, no.5, pp.490-499, 2017 (SCI-Expanded)
2017
2017Investigation of neuronal auto-antibodies in systemic lupus erythematosus patients with epilepsy
Karaaslan Z., Ekizoglu E., Tekturk P., Erdag E., Tuzun E., Bebek N., et al.
EPILEPSY RESEARCH
, pp.132-137, 2017 (SCI-Expanded)
2016
2016Brain Infiltration of Immune Cells in CASPR2-Antibody Associated Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
Unverengil G., Vanli Yavuz E. N., Tuzun E., Erdag E., Kabadayi S., Bilgic B., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.53, no.4, pp.344-347, 2016 (SCI-Expanded)
2016
2016NMDA receptor encephalitis with cancer of unknown primary origin
Çoban A., GÜNDOGDU G., Poyraz M., Yegen G., DEMIRTAŞ-TATLIDEDE A., Bilgiç B., et al.
TUMORI
, vol.102, 2016 (SCI-Expanded)
2016
201636th International Symposium on Intensive Care and Emergency Medicine: Brussels, Belgium. 15-18 March 2016.
Tüzün E., Şentürk E., Esen F., Orhun G., Kaya M., Küçükerden M., et al.
Critical Care , vol.20, pp.347, 2016 (SCI-Expanded)
2016
2016Reduced fecal GABA levels in multiple sclerosis patients
Yalcinkaya N., Akcan U., Orcen A., Kucukali C. İ., Tuzun E., TURKOGLU R., et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS
, pp.60-61, 2016 (SCI-Expanded)
2016
2016Chemokine and Chemokine Receptor Polymorphisms in Bipolar Disorder
Tokaç D., Tuzun E., GULEC H., Yilmaz V., Bireller E. S., Cakmakoglu B., et al.
PSYCHIATRY INVESTIGATION
, vol.13, no.5, pp.541-548, 2016 (SCI-Expanded)
2016
2016Expression of switch-associated protein 70 is associated with lymphocyte activation and reduced disability in multiple sclerosis
Türkoğlu R., özyurt S., Ulusoy C. A., ERDAG E., Tuzun E.
IMMUNOLOGY LETTERS
, vol.177, pp.75-77, 2016 (SCI-Expanded)
2016
2016Chemokine gene variants in schizophrenia
Dasdemir S., Kucukali C. I., Bireller E. S., Tuzun E., Cakmakoglu B.
NORDIC JOURNAL OF PSYCHIATRY
, vol.70, no.6, pp.407-412, 2016 (SCI-Expanded)
2016
2016Neuronal autoantibodies in mesial temporal lobe epilepsy with hippocampal sclerosis
Vanli-Yavuz E. N., Erdag E., Tuzun E., Ekizoglu E., Baysal-Kirac L., Ulusoy C. A., et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
, vol.87, no.7, pp.684-692, 2016 (SCI-Expanded)
2016
2016Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS
Oeckl P., Jardel C., Salachas F., Lamari F., Andersen P. M., Bowser R., et al.
AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION
, vol.17, pp.404-413, 2016 (SCI-Expanded)
2016
2016Are There Any Specific EEG Findings in Autoimmune Epilepsies?
Baysal-Kirac L., Tuzun E., ALTINDAG E., Ekizoglu E., KINAY D., Bilgic B., et al.
CLINICAL EEG AND NEUROSCIENCE
, no.3, pp.224-234, 2016 (SCI-Expanded)
2016
2016MuSK induced experimental autoimmune myasthenia gravis does not require IgG1 antibody to MuSK
Kucukerden M., Huda R., Tuzun E., Yilmaz A., Skriapa L., Trakas N., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.295, pp.84-92, 2016 (SCI-Expanded)
2016
2016Neuronal autoantibodies in patients with Rasmussen's encephalitis
Samanci B., Tekturk P., Tuzun E., Erdag E., KINAY D., Yapici Z., et al.
EPILEPTIC DISORDERS
, no.2, pp.204-210, 2016 (SCI-Expanded)
2016
2016The Owner and Responsible Manager on behalf of Turkish Neuropsychiatric Society (President)
Atbasoglu E. C., Tuzun E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.53, no.2, 2016 (SCI-Expanded)
2016
2016Behcet's Disease and Nervous System Involvement
Kurtuncu M., Tuzun E., AKMAN-DEMIR G.
CURRENT TREATMENT OPTIONS IN NEUROLOGY
, vol.18, no.5, 2016 (SCI-Expanded)
2016
2016Autoantibodies to Neurotransmitter Receptors and Ion Channels in Psychotic Disorders
Tuzun E.
KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY
, vol.26, no.1, pp.75-82, 2016 (SCI-Expanded)
2016
2016Increased complexin-1 and decreased miR-185 expression levels in Beh‡et's disease with and without neurological involvement
Ugurel E., Sehitoglu E., Tuzun E., Kurtuncu M., Coban A., Vural B.
NEUROLOGICAL SCIENCES
, no.3, pp.411-416, 2016 (SCI-Expanded)
2016
2016Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings
Baysal-Kirac L., Tuzun E., Erdag E., Ulusoy C., Vanli-Yavuz E. N., Ekizoglu E., et al.
JOURNAL OF NEUROLOGY
, vol.263, no.3, pp.455-466, 2016 (SCI-Expanded)
2016
2016First-episode psychotic disorder improving after immunotherapy
Gungor I., Derin S., Tekturk P., Tuzun E., Bilgic B., Cakir S.
ACTA NEUROLOGICA BELGICA
, vol.116, no.1, pp.113-114, 2016 (SCI-Expanded)
2016
2016Expression changes of genes associated with apoptosis and survival processes in Parkinson's disease
Yalcinkaya N., Haytural H., Bilgic B., Ozdemir O., Hanagasi H. A., Kucukali C. I., et al.
NEUROSCIENCE LETTERS
, vol.615, pp.72-77, 2016 (SCI-Expanded)
2016
2016Obturator mononeuropathy due to adenocarcinoma of unknown primary origin
TURKOGLU R., GENCER M., AKER F. V., MERIC K., GOKCEER S. Y., Coban A., et al.
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
, no.6, pp.882-883, 2016 (SCI-Expanded)
2016
2016Limbic Encephalitis Associated with Sjogren's Syndrome: Report of Three Cases
Coban A., Ozyurt S., Meric K., Misirli H., Tuzun E., Turkoglu R.
INTERNAL MEDICINE
, vol.55, no.16, pp.2285-2289, 2016 (SCI-Expanded)
2016
2016Association Between Polymorphisms of DNA Repair Genes and Risk of Schizophrenia
ODEMIS S., Tuzun E., GULEC H., SEMIZ U. B., Dasdemir S., Kucuk M., et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS
, no.1, pp.11-17, 2016 (SCI-Expanded)
2015
2015Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in MuSK-immunized mice.
Ulusoy C. A., Zibandeh N., Yildirim S., TRAKAS N., ZISIMOPOULOU P., Kucukerden M., et al.
Journal of neuroinflammation
, vol.12, pp.231, 2015 (SCI-Expanded)
2015
2015Ocular myasthenia gravis induced by human acetylcholine receptor epsilon subunit immunization in HLA DR3 transgenic mice
WU X., Tuzun E., SAINI S. S., WANG J., LI J., AGUILERA-AGUIRRE L., et al.
IMMUNOLOGY LETTERS
, vol.168, no.2, pp.306-312, 2015 (SCI-Expanded)
2015
2015Oligoclonal bands and increased cytokine levels in idiopathic intracranial hypertension
Altiokka-Uzun G., Tuzun E., Ekizoglu E., Ulusoy C. A., Yentur S., Kurtuncu M., et al.
CEPHALALGIA
, no.13, pp.1153-1161, 2015 (SCI-Expanded)
2015
2015Behcet's disease patients with multiple sclerosis-like features: discriminative value of Barkhof criteria
AKMAN-DEMIR G., Mutlu M. O., KIYAT-ARAMER A., Shugaiv E., Kurtuncu M., Tugal-Tutkun I., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, vol.33, no.6, 2015 (SCI-Expanded)
2015
2015Reduced muscle mitochondrial enzyme activity in MuSK-immunized mice.
Ozkok E., Durmus H., Yetimler B., Tasli H., TRAKAS N., Ulusoy C. A., et al.
Clinical neuropathology
, vol.34, no.6, pp.359-63, 2015 (SCI-Expanded)
2015
2015Reduced serum vitamin D levels in neuromyelitis optica
Tuzun E., Kucukhuseyin Ö., Kurtuncu M., TURKOGLU R., Yaylim I.
NEUROLOGICAL SCIENCES
, no.9, pp.1701-1702, 2015 (SCI-Expanded)
2015
2015A case of hyperkinetic movement disorder associated with LGI1 antibodies
Erer-Ozbek S., Yapici Z., Tuzun E., Giris M., Duran S., Taskapilioglu O., et al.
TURKISH JOURNAL OF PEDIATRICS
, vol.57, no.5, pp.514-517, 2015 (SCI-Expanded)
2015
2015The association between obesity and oligoclonal band formation in multiple sclerosis patients
Coban A., çevik D., özyurt S., Gencer M., Tuzun E., TURKOGLU R.
OBESITY RESEARCH & CLINICAL PRACTICE
, no.5, pp.533-535, 2015 (SCI-Expanded)
2015
2015Guidelines for standard preclinical experiments in the mouse model of myasthenia gravis induced by acetylcholine receptor immunization
Tuzun E., BERRIH-AKNIN S., Brenner T., Kusner L. L., LE PANSE R., YANG H., et al.
EXPERIMENTAL NEUROLOGY
, vol.270, pp.11-17, 2015 (SCI-Expanded)
2015
2015Antibodies to DNA repair proteins in headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL) patients
Erdag E., ÇELEBİSOY N., YÜCEYAR A. N., Kurtuncu M., Vural B., Tuzun E.
ACTA NEUROLOGICA BELGICA
, vol.115, no.2, pp.137-140, 2015 (SCI-Expanded)
2015
2015Epigenetics of Multiple Sclerosis: An Updated Review
Kucukali C. İ., Kurtuncu M., Coban A., Cebi M., Tuzun E.
NEUROMOLECULAR MEDICINE
, no.2, pp.83-96, 2015 (SCI-Expanded)
2015
2015Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis
PETEK-BALCI B., Coban A., Shugaiv E., TURKOGLU R., Ulusoy C., Icoz S., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, no.5, pp.352-356, 2015 (SCI-Expanded)
2015
2015Differential cytokine changes in patients with myasthenia gravis with antibodies against AChR and MuSK
Yilmaz V., Oflazer P., AYSAL F., Durmus H., Poulas K., Yentur S. P., et al.
PLoS ONE
, vol.10, no.4, 2015 (SCI-Expanded)
2015
2015IgG1 deficiency exacerbates experimental autoimmune myasthenia gravis in BALB/c mice
HUDA R., STRAIT R. T., Tuzun E., FINKELMAN F. D., CHRISTADOSS P.
JOURNAL OF NEUROIMMUNOLOGY
, vol.281, pp.68-72, 2015 (SCI-Expanded)
2015
2015Peripheral nerve hyperexcitability syndromes
Kucukali C. İ., Kurtuncu M., Akcay H. I., Tuzun E., Oge A. E.
REVIEWS IN THE NEUROSCIENCES
, no.2, pp.239-251, 2015 (SCI-Expanded)
2015
2015Evaluation of Paraoxonase 1 Polymorphisms in Patients with Bipolar Disorder
Kucukali C. İ., Ulusoy C., OZKAN O., Orhan N., GULEC H., Erdag E., et al.
IN VIVO
, vol.29, no.1, pp.103-108, 2015 (SCI-Expanded)
2015
2015Uveitis as a prognostic factor in multiple sclerosis
Shugaiv E., Tuzun E., Kurtuncu M., Kiyat-Atamer A., Coban A., Akman-Demir G., et al.
MULTIPLE SCLEROSIS JOURNAL
, no.1, pp.105-107, 2015 (SCI-Expanded)
2015
2015Febrile Infection Related Epilepsy Syndrome (FIRES) in Adults Imitating Limbic Encephalitis
Tekturk P., Baykan B., Tuzun E.
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
, vol.32, no.1, pp.243-249, 2015 (SCI-Expanded)
2014
2014Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients
Kucukali C. İ., Haytural H., Benbir G., Coban A., Ulusoy C., Giris M., et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES
, no.1-2, pp.353-355, 2014 (SCI-Expanded)
2014
2014Sorcin antibody as a possible predictive factor in conversion from radiologically isolated syndrome to multiple sclerosis: a preliminary study
Sehitoglu E., Cavus F., Ulusoy C., Kucukerden M., Orcen A., Akbas-Demir D., et al.
INFLAMMATION RESEARCH
, no.10, pp.799-801, 2014 (SCI-Expanded)
2014
2014Guillain-Barre Syndrome in a Patient with Primary Extranodal Intestinal Non-Hodgkin's Lymphoma: Paraneoplastic, Drug Induced or Coincidental?
Atamer A. K., Okutur K., Tuzun E., Hasbal B., BOYACIYAN A., Krespi Y., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.51, no.3, pp.288-292, 2014 (SCI-Expanded)
2014
2014Targeting complement system to treat myasthenia gravis
HUDA R., Tuzun E., CHRISTADOSS P.
REVIEWS IN THE NEUROSCIENCES
, vol.25, no.4, pp.575-583, 2014 (SCI-Expanded)
2014
2014Calcium channel antibodies in patients with absence epilepsy
Tekturk P., Baykan B., Ekizoglu E., Ulusoy C., Aydin-Ozemir Z., Icoz S., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, vol.124, no.7, pp.486-490, 2014 (SCI-Expanded)
2014
2014Increased IL-23 receptor, TNF-alpha and IL-6 expression in individuals with the IL23R-IL12R132 locus polymorphism
Cavus F., Ulusoy C., Orcen A., Gül A., Tuzun E., Vural B.
IMMUNOLOGY LETTERS
, vol.160, no.1, pp.96-98, 2014 (SCI-Expanded)
2014
2014Anti NMDA receptor encephalitis associated with thymic hyperplasia: A case report
Yilmaz B., Mastanzade T., Ozkara C., Erkol O., Tuzun E.
NEUROLOGY INDIA
, vol.62, no.3, pp.331-332, 2014 (SCI-Expanded)
2014
2014Investigation of neuronal autoantibodies in two different focal epilepsy syndromes
Ekizoglu E., Tuzun E., Woodhall M., Lang B., Jacobson L., Icoz S., et al.
EPILEPSIA
, vol.55, no.3, pp.414-422, 2014 (SCI-Expanded)
2014
2014Evaluation of incidence and clinical features of antibody-Associated autoimmune encephalitis mimicking dementia
Coban A., Kucukali C. I., Bilgic B., Yalcinkaya N., Haytural H., Ulusoy C., et al.
Behavioural Neurology
, vol.2014, 2014 (SCI-Expanded)
2014
2014Aquaporin-1 Antibody in Neuromyelitis Optica Patients
Tuzun E., TZARTOS J., Ekizoglu E., STERGIOU C., ZISIMOPOULOU P., Coban A., et al.
EUROPEAN NEUROLOGY
, no.5-6, pp.271-272, 2014 (SCI-Expanded)
2014
2014Preferential production of IgG1, IL-4 and IL-10 in MuSK-immunized mice
Ulusoy C. A., KIM E., Tuzun E., HUDA R., Yilmaz V., Poulas K., et al.
Clinical Immunology
, vol.151, no.2, pp.155-163, 2014 (SCI-Expanded)
2014
2014Switch-Associated Protein 70 Antibodies in Multiple Sclerosis: Possible Association with Disease Progression
TURKOGLU R., Gencer M., EKMEKCI D., Ulusoy C., Erdag E., Sehitoglu E., et al.
MEDICAL PRINCIPLES AND PRACTICE
, no.3, pp.239-245, 2014 (SCI-Expanded)
2013
2013Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica
Woodhall M., Coban A., Waters P., Eldzoglu E., Kurtuncu M., Shugaiv E., et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES
, no.1-2, pp.221-223, 2013 (SCI-Expanded)
2013
2013Expression analysis and clinical correlation of aquaporin 1 and 4 genes in human hippocampal sclerosis
Bebek N., Özdemir Ö., Sayitoglu M., Hatirnaz O., Baykan B., Gurses C., et al.
JOURNAL OF CLINICAL NEUROSCIENCE
, vol.20, no.11, pp.1564-1570, 2013 (SCI-Expanded)
2013
2013GUILLAIN-BARRE-LIKE SYNDROME ASSOCIATED WITH LUNG ADENOCARCINOMA AND CASPR2 ANTIBODIES
Tuzun E., Kinay D., Hacohen Y., Aysal F., Vincent A.
MUSCLE & NERVE
, vol.48, no.5, pp.836-837, 2013 (SCI-Expanded)
2013
2013Mitochondrial carrier homolog 1 (Mtch1) antibodies in neuro-Behcet's disease
Vural B., Sehitoglu E., Cavus F., Yalcinkaya N., Haytural H., Kucukerden M., et al.
JOURNAL OF NEUROIMMUNOLOGY
, no.1-2, pp.139-144, 2013 (SCI-Expanded)
2013
2013Reduced Orexin-A Levels in Frontotemporal Dementia: Possible Association With Sleep Disturbance
Coban A., Bilgic B., Lohmann E., Kucukali C. I., Benbir G., Karadeniz D., et al.
AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS
, vol.28, no.6, pp.606-611, 2013 (SCI-Expanded)
2013
2013Serum anti-neuronal antibodies in amyotrophic lateral sclerosis
Coban A., Ulusoy C. A., Giris M., Turan S., TUERKOGLU R., Tuzun E., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, no.8, pp.557-562, 2013 (SCI-Expanded)
2013
2013Complement associated pathogenic mechanisms in myasthenia gravis
Tuzun E., CHRISTADOSS P.
AUTOIMMUNITY REVIEWS
, vol.12, no.9, pp.904-911, 2013 (SCI-Expanded)
2013
2013Non-Convulsive Status Epilepticus Associated With Glutamic Acid Decarboxylase Antibody
Cikrikcili U., Ulusoy C. A., Turan S., Yildiz S., Bilgic B., Hanagasi H. A., et al.
CLINICAL EEG AND NEUROSCIENCE
, vol.44, no.3, pp.232-236, 2013 (SCI-Expanded)
2013
2013Impact of cigarette smoking on conversion from clinically isolated syndrome to clinically definite multiple sclerosis
Arikanoglu A., Shugaiv E., Tuzun E., Erakso M.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, vol.123, no.7, pp.476-479, 2013 (SCI-Expanded)
2013
2013Complement C2 siRNA mediated therapy of myasthenia gravis in mice
HUDA R., Tuzun E., CHRISTADOSS P.
JOURNAL OF AUTOIMMUNITY
, vol.42, pp.94-104, 2013 (SCI-Expanded)
2013
2013Coexistence of Guillain-Barre syndrome and Behcet's disease
Shugaiv E., Kiyat-Atamer A., Tuzun E., Deymeer F., Oflazer P., Parman Y., et al.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, no.3, 2013 (SCI-Expanded)
2013
2013Peripheral Neuropathy Associated With Antiglutamic Acid Decarboxylase Antibodies
Saltik S., Turkes M., Tuzun E., Cakir A., Ulusoy C.
PEDIATRIC NEUROLOGY
, vol.48, no.5, pp.403-406, 2013 (SCI-Expanded)
2013
2013Long-term MRI findings in neuromyelitis optica: seropositive versus seronegative patients
KIYAT-ATAMER A., Ekizoglu E., Tuzun E., Kurtuncu M., Shugaiv E., AKMAN-DEMIR G., et al.
EUROPEAN JOURNAL OF NEUROLOGY
, no.5, pp.781-787, 2013 (SCI-Expanded)
2013
2013Aquaporin-4 antibody seropositivity in myasthenia gravis patients with thymoma
Ekizoglu E., Yilmaz V., Icoz S., Birisik O., Tuzun E., Akman-Demir G., et al.
Muscle and Nerve
, vol.47, no.2, pp.306-307, 2013 (SCI-Expanded)
2013
2013Anti-N-methyl-D-aspartate receptor encephalitis with minimal cortical impairment
Tuzun E., TURKOGLU R., Yumerhodzha S. M., Erdag E., Eraksoy M., Akman-Demir G.
NEUROLOGICAL SCIENCES
, vol.34, no.1, pp.111-113, 2013 (SCI-Expanded)
2013
2013Kleptomania in Patients with Neuro-Behcet's Disease
Shugaiv E., Kiyat-Atamer A., Tuzun E., Kurtuncu M., Baral-Kulaksizoglu I., Demir G. A.
MEDICAL PRINCIPLES AND PRACTICE
, no.6, pp.550-554, 2013 (SCI-Expanded)
2013
2013CACNA1H antibodies associated with headache with neurological deficits and cerebrospinal fluid lymphocytosis (HaNDL)
Kurtuncu M., KAYA D., Zuliani L., Erdag E., Icoz S., Ugurel E., et al.
CEPHALALGIA
, vol.33, no.2, pp.123-129, 2013 (SCI-Expanded)
2013
2013Progressive Encephalomyelitis with Rigidity and Myoclonus: A Syndrome with Diverse Clinical Features and Antibody Responses
Shugaiv E., Leite M. I., Sehitoglu E., Woodhall M., Cavus F., Waters P., et al.
EUROPEAN NEUROLOGY
, no.5, pp.257-262, 2013 (SCI-Expanded)
2013
2013Comparative clinical characteristics of early- and adult-onset multiple sclerosis patients with seizures
Durmus H., Kurtuncu M., Tuzun E., Pehlivan M., Akman-Demir G., Yapici Z., et al.
Acta Neurologica Belgica
, vol.113, no.4, pp.421-426, 2013 (SCI-Expanded)
2013
2013Syndrome of Headache Accompanied with Transient Neurologic Deficits and Cerebrospinal Fluid Lymphocytosis
Coban A., Shugaiv E., Tuzun E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, pp.52-55, 2013 (SCI-Expanded)
2012
2012Novel animal models of acetylcholine receptor antibody-related myasthenia gravis.
Tuezuen E., ALLMAN W., Ulusoy C. A., YANG H., CHRISTADOSS P.
Annals of the New York Academy of Sciences
, vol.1274, pp.133-9, 2012 (SCI-Expanded)
2012
2012Isolated dysphagia due to aquaporin-4 autoimmunity
TURKOGLU R., Kiyat-Atamer A., Tuzun E., Akman-Demir G.
TURKISH JOURNAL OF GASTROENTEROLOGY
, vol.23, no.6, pp.804-805, 2012 (SCI-Expanded)
2012
2012Cognitive Impairment in Neuro-Behcet's Disease and Multiple Sclerosis: A Comparative Study
Gunduz T., Emir O., Kurtuncu M., Mutlu M., Tumac A., Akca S., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, no.11, pp.650-656, 2012 (SCI-Expanded)
2012
2012Switch-associated protein 70 antibodies in multiple sclerosis: relationship between increased serum levels and clinical relapse
Erdag E., Tuzun E., Ugurel E., Cavus F., Sehitoglu E., Giris M., et al.
INFLAMMATION RESEARCH
, vol.61, no.9, pp.927-930, 2012 (SCI-Expanded)
2012
2012CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis
ALLMAN W., QI H., SAINI S. S., LI J., Tuzun E., CHRISTADOSS P.
JOURNAL OF NEUROIMMUNOLOGY
, vol.249, pp.1-7, 2012 (SCI-Expanded)
2012
2012Effect of short-term interferon-beta treatment on cytokines in multiple sclerosis: Significant modulation of IL-17 and IL-23
Kurtuncu M., Tuzun E., TURKOGLU R., PETEK-BALCI B., Icoz S., Pehlivan M., et al.
CYTOKINE
, vol.59, no.2, pp.400-402, 2012 (SCI-Expanded)
2012
2012Evaluation of Glutathione S-Transferase P1 Polymorphisms (Ile105Val and Ala114Val) in Patients with Small Cell Lung Cancer
Vural B., Yakar F., Derin D., Saip P., Yakar A., Demirkan A., et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS
, vol.16, no.7, pp.701-706, 2012 (SCI-Expanded)
2012
2012Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: Favorable response to cancer treatment
Armagan H., Tuzun E., Icoz S., Birisik O., Ulusoy C., Demir G., et al.
JOURNAL OF SPINAL CORD MEDICINE
, vol.35, no.4, pp.267-269, 2012 (SCI-Expanded)
2012
2012Comparison of the Cytokine Profiles of Patients With Neuronal-Antibody-Associated Central Nervous System Disorders
Ulusoy C., Tuzun E., Kurtuncu M., TURKOGLU R., Akman-Demir G., Eraksoy M.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, no.6, pp.284-289, 2012 (SCI-Expanded)
2012
2012Ocular and generalized myasthenia gravis induced by human acetylcholine receptor ? subunit immunization
WU X., Tuzun E., LI J., XIAO T., SAINI S. S., QI H., et al.
MUSCLE & NERVE
, vol.45, no.2, pp.209-216, 2012 (SCI-Expanded)
2012
2012Aquaporin-4 antibodies are not present in patients with idiopathic intracranial hypertension
Ekizoglu E., Icoz S., Tuzun E., Birisik O., Kocasoy-Orhan E., Akman-Demir G., et al.
CEPHALALGIA
, vol.32, no.3, pp.198-202, 2012 (SCI-Expanded)
2011
2011The Role of B Cells in Multiple Sclerosis Pathogenesis and Monoclonal Antibody Treatments Targeting B Cells
Tuzun E.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.48, pp.73-78, 2011 (SCI-Expanded)
2011
2011Experimental Autoimmune Myasthenia Gravis in the Mouse
Wu B., Goluzsko E., Huda R., TÜZÜN E., Christadoss P.
CURRENT OPINION IN IMMUNOLOGY , vol.95, no.15, pp.1-26, 2011 (SCI-Expanded)
2011
2011Anti-neuronal and stress-induced-phosphoprotein 1 antibodies in neuro-Behcet's disease
Vural B., Ugurel E., Tuzun E., Kurtuncu M., Zuliani L., Cavus F., et al.
JOURNAL OF NEUROIMMUNOLOGY
, no.1-2, pp.91-97, 2011 (SCI-Expanded)
2011
2011Increased complement consumption in musk-antibody-positive myasthenia gravis patients
Tuzun E., Yilmaz V., Parman Y., Oflazer P., Deymee F., Saruhan-Direskeneli G.
Medical Principles and Practice
, vol.20, no.6, pp.581-583, 2011 (SCI-Expanded)
2011
2011Increased Alcohol Consumption Rates of Multiple Sclerosis Patients and Their Parents
Pehlivan M., Kurtuncu M., Yargic I., Tuzun E.
AMERICAN JOURNAL ON ADDICTIONS
, vol.20, no.5, pp.488-489, 2011 (SSCI)
2011
2011Complement and cytokine based therapeutic strategies in myasthenia gravis
Tuezuen E., Huda R., Christadoss P.
JOURNAL OF AUTOIMMUNITY
, vol.37, no.2, pp.136-143, 2011 (SCI-Expanded)
2011
2011Characterization of peripheral blood acetylcholine receptor-binding B cells in experimental myasthenia gravis
ALLMAN W., SAINI S. S., Tuzun E., CHRISTADOSS P.
Cellular Immunology
, vol.271, no.2, pp.292-298, 2011 (SCI-Expanded)
2011
2011The comparison of socio-economic conditions and personal hygiene habits of neuro-Behcet's disease and multiple sclerosis patients
Pehlivan M., Kurtuncu M., Tuzun E., Shugaiv E., Mutlu M., Eraksoy M., et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH
, vol.214, no.4, pp.335-337, 2011 (SCI-Expanded)
2011
2011Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behcet's disease with parenchymal involvement: presentation of four cases
Shugaiv E., Tuzun E., Mutlu M. O., Kiyat-Atamer A., Kurtuncu M., Akman-Demir G.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
, no.4, 2011 (SCI-Expanded)
2011
2011Steroid-responsive recurrent limbic encephalitis associated with small cell lung cancer and neuropil antibodies
Tuzun E., Yaka E., Zuliani L., Icoz S., Baklan B., Birisik O., et al.
ACTA NEUROLOGICA BELGICA
, vol.111, no.2, pp.139-142, 2011 (SCI-Expanded)
2011
2011Genetic deficiency of estrogen receptor alpha fails to influence experimental autoimmune myasthenia gravis pathogenesis
QI H., LI J., ALLMAN W., SAINI S. S., Tuezuen E., WU X., et al.
JOURNAL OF NEUROIMMUNOLOGY
, vol.234, pp.165-167, 2011 (SCI-Expanded)
2011
2011Enhanced complement consumption in neuromyelitis optica and Behcet's disease patients
Tuzun E., Kurtuncu M., TURKOGLU R., Icoz S., Pehlivan M., Birisik O., et al.
JOURNAL OF NEUROIMMUNOLOGY
, no.1-2, pp.211-215, 2011 (SCI-Expanded)
2011
2011Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients
Akman-Demir G., Tuzun E., Waters P., Icoz S., Kurtuncu M., Jarius S., et al.
JOURNAL OF NEUROLOGY
, no.3, pp.464-470, 2011 (SCI-Expanded)
2011
2011Antineuronal Antibodies in Migraine Patients With White Matter Lesions
TURKOGLU R., Tuzun E., Icoz S., Birisik O., Erdag E., Kurtuncu M., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, no.1, pp.33-36, 2011 (SCI-Expanded)
2011
2011Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis
Tuzun E., Erdag E., Durmus H., Brenner T., Turkoglu R., Kurtuncu M., et al.
NEUROLOGY INDIA
, vol.59, no.1, pp.47-50, 2011 (SCI-Expanded)
2010
2010Bickerstaff's encephalitis and Miller Fisher syndrome associated with voltage-gated potassium channel and novel anti-neuronal antibodies
Tuzun E., Kurtuncu M., Lang B., Icoz S., Akman-Demir G., Eraksoy M., et al.
EUROPEAN JOURNAL OF NEUROLOGY
, no.10, pp.1304-1307, 2010 (SCI-Expanded)
2010
2010Unihemispheric acute disseminated encephalomyelitis: A case report Tek hemisferi tutan akut dissemine ensefalomiyelit: Olgu sunumu
Durmus H., TURKOGLU R., Tuzun E.
Noropsikiyatri Arsivi
, vol.47, no.2, pp.166-168, 2010 (SCI-Expanded)
2010
2010Amphiphysin Autoimmunity: Associated Neurological Syndromes and Tumors in The Turkish Population
Tuzun E., Bebek N., Icoz S., Durmus H., Kurtuncu M., Gurses C., et al.
JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH
, vol.27, no.2, pp.121-126, 2010 (SCI-Expanded)
2010
2010Steroid-Responsive Myeloneuropathy Associated With Antithyroid Antibodies
TURKOGLU R., Tuzun E.
JOURNAL OF SPINAL CORD MEDICINE
, vol.33, no.3, pp.278-280, 2010 (SCI-Expanded)
2010
2010A rare case of multiple sclerosis and cerebral hemorrhage associated with osteopetrosis
KAYA D., Tüzün E., DİNÇER A., PAMİR M. N., Kürtüncü M.
DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY
, no.1, pp.16-19, 2010 (SCI-Expanded)
2010
2010Rare Neurological Syndromes Associated with Systemic Lupus Erythematosus
Durmus H., Tuzun E., Alpay N., Icoz S., Kurtuncu M., Demir G. A.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, vol.47, no.1, pp.81-82, 2010 (SCI-Expanded)
2010
2010Enhanced IL-6 Production in Aquaporin-4 Antibody Positive Neuromyelitis Optica Patients
Icoz S., Tuzun E., Kurtuncu M., Durmus H., Mutlu M., Eraksoy M., et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE
, no.1, pp.71-75, 2010 (SCI-Expanded)
2010
2010Impact of Earthquake on Multiple Sclerosis Attacks
Tuzun E., Polat A., Akman-Demir G., Kurtuncu M., Mutlu M., Aksay B., et al.
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY
, no.4, pp.324-327, 2010 (SCI-Expanded)
2010
2010Sensorimotor neuropathy associated with endometrioid endometrial carcinoma
Durmus H., Tuzun E., Icoz S., Akman-Demir G., Parman Y.
European Journal of Obstetrics and Gynecology and Reproductive Biology
, vol.150, no.2, pp.216-217, 2010 (SCI-Expanded)
2009
2009Brainstem encephalitis following influenza vaccination: Favorable response to steroid treatment
TURKOGLU R., Tuzun E.
VACCINE
, vol.27, no.52, pp.7253-7256, 2009 (SCI-Expanded)
2009
2009Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma
Tuezuen E., Zhou L., Baehring J. M., Bannykh S., Rosenfeld M. R., Dalmau J.
ACTA NEUROPATHOLOGICA
, vol.118, no.6, pp.737-743, 2009 (SCI-Expanded)
2009
2009